Long-range surface plasmon aptasensor for label-free monitoring of vancomycin

Vancomycin (VCM) causes poisoning symptoms at high concentrations; thus, therapeutic drug monitoring is recommended to measure and control blood levels regularly. However, blood analysis at regular intervals does not allow knowing the detailed temporal change in concentration. To address this challenge, we developed a long-range surface plasmon (LRSP) aptasensor for measuring VCM label-free and real-time by combining a sensitive LRSP sensor and a peptide aptamer with a VCM recognition site. First, three different biosensors for VCM were compared. One was prepared by immobilizing the peptide aptamer directly on (Direct-Apt) or via a self-assembled monolayer (SAM) on a gold surface (SAM-Apt). The other used anti-VCM antibodies immobilized on a gold surface via the SAM (SAM-Ab). The Direct-Apt showed larger sensor output to VCM than the other biosensors. The dynamic range for VCM was 0.78-100 mu M, including the therapeutic range (6.9-13.8 mu M). The Direct-Apt also showed the sensor output only from VCM among four different antibiotics, demonstrating the high selectivity for VCM. The VCM captured by the aptamer could be removed by rinsing with phosphate-buffered saline. The measurement was rapid, with 72-and 77-sec response and recovery times, allowing not only repeated but also real-time measurements. Finally, the Direct-Apt in 20% serum solutions showed com-parable sensitivity to VCM in the buffer solution, indicating high capability for real-sample.

Automated summary

This study developed a long-range surface plasmon (LRSP) aptasensor for label-free and real-time measurement of vancomycin (VCM). The sensor showed high selectivity for VCM and a dynamic range that covered the therapeutic range. It also demonstrated rapid response and recovery times, allowing repeated and real-time measurements.